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Differentiation of oral bacteria in  
in vitro cultures and human 
saliva by secondary electrospray 
ionization – mass spectrometry
Lukas Bregy1, Annick R. Müggler2, Pablo Martinez-Lozano Sinues1, Diego García-Gómez1, 
Yannick Suter1, Georgios N. Belibasakis3, Malcolm Kohler4, Patrick R. Schmidlin2 & 
Renato Zenobi1
The detection of bacterial-specific volatile metabolites may be a valuable tool to predict infection. 
Here we applied a real-time mass spectrometric technique to investigate differences in volatile 
metabolic profiles of oral bacteria that cause periodontitis. We coupled a secondary electrospray 
ionization (SESI) source to a commercial high-resolution mass spectrometer to interrogate 
the headspace from bacterial cultures and human saliva. We identified 120 potential markers 
characteristic for periodontal pathogens Aggregatibacter actinomycetemcomitans (n = 13), 
Porphyromonas gingivalis (n = 70), Tanerella forsythia (n = 30) and Treponema denticola (n = 7) in in 
vitro cultures. In a second proof-of-principle phase, we found 18 (P. gingivalis, T. forsythia and T. 
denticola) of the 120 in vitro compounds in the saliva from a periodontitis patient with confirmed 
infection with P. gingivalis, T. forsythia and T. denticola with enhanced ion intensity compared to 
two healthy controls. In conclusion, this method has the ability to identify individual metabolites of 
microbial pathogens in a complex medium such as saliva.
Periodontal bacterial infections are one of the most severe dental diseases, often even leading to tooth loss 
if untreated1. The disease is characterized by a progressive damage of the periodontal soft and hard tissue 
and is frequently accompanied by four types of bacteria that can colonize the mouth: Aggregatibacter 
actinomycetemcomitans, Porphyromonas gingivalis, Tanerella forsythia and Treponema denticola. Often, 
patients suffering of periodontitis only show indicating symptoms at a late stage, when the development 
of the disease has led to enhanced tooth mobility.
Today, dentists are identifying this disease mainly by visual inspections of the teeth, looking for spe-
cific signs of inflammation like bleeding upon probing and increased periodontal pocket depths2. In 
addition, bacteria samples from periodontal pockets can nowadays be analyzed using microbiological 
techniques to identify potential disease related bacterial species3. However there is still a lack of methods 
with the combined power of fast, sensitive and specific analysis of such bacteria. Early on, it was recog-
nized that saliva is an ideal fluid to analyze the processes in the mouth and it is being used for clinical 
diagnostics. Saliva contains many different compound classes, including small molecules, proteins or 
enzymes, which also means that it contains rich information related to processes taking place in the oral 
cavity4.
1Department of Chemistry and Applied Biosciences, ETH Zürich, Switzerland. 2Clinic of Preventive Dentistry, 
Periodontology and Cariology, Center of Dental Medicine, University of Zürich, Switzerland. 3Oral Microbiology and 
Immunology, Institute of Oral Biology, Center of Dental Medicine, University of Zürich Switzerland. 4Department 
of Pulmonology, University Hospital Zürich, Switzerland. Correspondence and requests for materials should be 
addressed to R.Z. (email: zenobi@org.chem.ethz.ch)
Received: 03 March 2015
Accepted: 17 September 2015
Published: 19 October 2015
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 5:15163 | DOi: 10.1038/srep15163
In the last decades, mass spectrometry has been shown to be a powerful tool to analyze biological 
samples like blood, urine, saliva, and breath, for applications in clinical chemistry and in toxicology5–7. 
Traditionally, hyphenated methods like gas chromatography – mass spectrometry (GC-MS) or liquid 
chromatography – mass spectrometry (LC-MS) were used to analyze the headspace and the culture 
solution of bacteria respectively8. After some pioneering developments9–12, several real-time techniques 
for the analysis of gas and vapor samples were developed in recent years, e.g., proton transfer reaction – 
mass spectrometry (PTR-MS) and selected ion flow tube – mass spectrometry (SIFT-MS). A similarly 
powerful analytical tool is secondary electrospray ionization – mass spectrometry (SESI-MS), where 
vapor species are ionized at atmospheric pressure and are subsequently detected by any commercial mass 
spectrometer of choice. It has shown promise in a number of applications calling for fast and sensitive 
analysis of vapors13–16. It has been extensively used for the analysis of volatile metabolic “fingerprints”, 
including bacterial species17–21. A key element is that, with minor modifications, one can take advan-
tage of the power of modern mass spectrometers, especially their high resolving power, sensitivity and 
MSMS capabilities. This is crucial in real-time analysis because, in the absence of prior chromatographic 
separation, metabolite detection and accurate identification relies exclusively in MS performance. As 
a result, SESI combined with high performance MS results in rich breathprints covering volatiles and 
semi-volatiles, e.g., fatty acids22.
Following the idea of fast, sensitive and selective diagnostics, e.g., in dentistry, we show here the first 
untargeted headspace analyses of oral bacteria A. actinomycetemcomitans, P. gingivalis, T. denticola and 
T. forsythia with high-resolution SESI-MS. In a first in vitro part of our study, we analyzed the headspace 
of 5 independent biological replicate cultures from each bacterium. In a second phase, we tested whether 
the set of molecules found to be discriminatory in the in vitro study could also be found in saliva samples 
from one periodontitis patient.
Results and Discussion
Untargeted bacteria culture headspace analysis. Figure 1 shows that SESI-MS is a suitable real-
time method to analyze volatiles accumulated in the headspace of bacteria medium. The total ion current 
from headspace injections of the four different bacteria strains and of the mixed medium is shown (total 
of 25 measurements; Panel A). Note how the total intensity rises sharply during the injection of the gas 
sample and decays within ~1 minute to the baseline level. Also of note is that the 25 mass spectromet-
ric measurements were completed within 30 minutes, without any sample pretreatment. Extracted ion 
time-profiles for four selected mass peaks are plotted (B-E). Importantly, the intensities of the biological 
replicates are in most cases comparable, with the exception of the first T. denticola biological replicate 
at m/z 120.0641, which shows a lower intensity. By mere visual inspection of the four m/z time-profiles 
Figure 1. Headspace analysis showing the total ion chromatogram (A) and extracted ion chromatograms of 
four bacteria specific compounds (B - E): m/z 85.0630 (A. actinomycetemcomitans specific), m/z 92.0486 (T. 
forsythia specific), m/z 120.0641 (T. denticola specific) and m/z 132.0995 (P. gingivalis specific).
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alone, one can already easily distinguish that each compound exhibit a different intensity in each of the 
bacterial strains investigated.
Figure 2 displays the data distribution per group for the selected features shown in Fig. 1. It can be 
noticed that the intensities of the biological replicates from one bacterial strain are significantly enhanced 
in comparison to the other three strains. With the exception of the T. denticola outlier for m/z 120.0641, 
these four volatiles alone could distinguish the four strains investigated. It is visible that the ion inten-
sities for the non-specific strains is not equal to zero. This is reasonable, since it is unlikely that these 
metabolites are completely unique to one strain, but rather likely that they are produced in higher con-
centrations for a specific strain.
Apart from these four examples, the volatile fingerprints of the bacterial strains revealed a total of 
120 bacteria-specific compounds (Table  1): 13 for A. actinomycetemcomitans, 70 for P. gingivalis, 7 for 
T. denticola and 30 for T. forsythia. The large number of P. gingivalis, A. actinomycetemcomitans and T. 
forsythia-specific compounds makes it very distinct, in contrast to T. denticola. Table 1 lists the molecu-
lar formulas of these compounds, along with p- and q-values. Supplementary Tables S1 and S2 provide 
further details on actual ion intensities for all bacterial cultures and culture medium; and pairwise com-
parisons, respectively.
For a better visualization, the 120 filtered mass features from all biological replicates from the four 
different bacteria strains were subjected to principal component analysis (PCA). Figure  3 shows the 
score plot for the first two principal components, explaining ~76% of the variance. It can be observed 
that the five biological replicates per strain tend to cluster together and each bacterial type occupies a 
distinct area. The first PC separates P. gingivalis and A. actinomycetemcomitans from the rest, whereas PC 
2 separates T. forsythia from the other three strains. With the combined information of these two axes it 
is possible to differentiate all four bacterial strains.
Targeted bacteria analysis in human saliva. In the second phase of this study, the set of 
bacteria-specific compounds found in vitro (Table  1, Tables S1 and S2) were sought in saliva samples 
from one patient and two healthy controls. The patient suffered a severe periodontitis, and P. gingivalis, 
T. denticola and T. forsythia bacteria were present. The number of bacteria was determined by the stand-
ard IAI Pado-Test 4.5: 0.45 ± 0.9 E6 Pg, 0.28 ± 0.53 E6 Td and 0.51 ± 1.02 E6 Tf bacteria (mean of the 
Figure 2. Plots showing the ion intensities of the headspace samples from all four bacteria cultures for 
four selected compounds m/z 85.0630 (Aa—A. actinomycetemcomitans specific), m/z 92.0486  
(Tf – T. forsythia specific), m/z 120.0641 (Td – T. denticola specific) and m/z 132.0995 (Pg – P. gingivalis 
specific). The horizontal red line represents the mean, while the vertical red line indicate standard deviation. 
The blue brackets connecting the boxes indicate a significant difference between the biological replicates 
originating from two bacterial strains. The number of stars indicate the range of p-values from the multiple 
comparison test (Tukey-Kramer procedure): * (0.01 < p  ≤ 0.05), ** (0.001 < p  ≤ 0.01) and *** (p ≤ 0.001).
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Bacterial 
strain m/z Sum formula
Mass deviation from 
experimental mass 
(ppm)
in vitro comparisons
Present in patient’s 
saliva  
(IAI Pado-Test 4.5)
Enhanced 
in patient 
vs. controls
Enhancement ratio
p value q value
patient/
control 1
patient/
control 2
Aa 43.0180 C2H3O 3.7 1.93E-05 1.32E-07 no not present – –
Aa 58.8706 – – 1.85E-03 4.13E-06 no no 0.18 0.15
Aa 58.9993 – – 2.04E-03 4.50E-06 no not present – –
Aa 59.0134 C2H3O2 11 3.32E-03 6.59E-06 no not present – –
Aa 59.0481 C3H7O 11 1.21E-03 3.11E-06 no no 0.22 0.15
Aa 65.0369 C5H5 26 3.35E-05 1.97E-07 no yes 27.42 88.89
Aa 67.0522 C5H7 1.9 8.09E-05 3.87E-07 no no 0.43 0.31
Aa 84.8031 – – 1.24E-03 3.13E-06 no not present – –
Aa 85.0630 C5H9O 3.4 8.50E-06 7.04E-08 no no 0.50 0.42
Aa 87.0667 C2H7N4 2 3.18E-04 1.16E-06 no not present – –
Aa 99.0778 C6H11O 12 1.92E-04 7.69E-07 no no 0.33 0.18
Aa 117.0886 C6H13O2 1.8 4.28E-04 1.43E-06 no no 1.23 1.33
Aa 144.1094 C6H14N3O4 24 1.29E-04 5.71E-07 no no 0.82 0.86
Pg 79.0189 C5H3O 1.8 6.18E-04 1.91E-06 yes yes 3.28 4.65
Pg 88.0738 C4H10NO 2.2 7.25E-08 2.20E-09 yes no 1.55 2.21
Pg 97.0258 C5H5O2 0.1 6.27E-06 5.50E-08 yes no 0.34 0.30
Pg 97.0619 C6H9O 0.9 1.48E-09 2.17E-10 yes no 0.47 0.48
Pg 100.0450 C4H6NO2 57 1.03E-04 4.61E-07 yes no 1.15 1.23
Pg 107.0669 C4H11O3 31 9.38E-04 2.64E-06 yes yes 3.06 3.53
Pg 110.0579 C6H8NO 19 3.39E-04 1.19E-06 yes no 1.13 1.40
Pg 111.0414 C6H7O2 3.2 8.31E-08 2.33E-09 yes no 0.37 0.38
Pg 111.0771 C7H11O 0.2 8.71E-09 4.82E-10 yes no 1.02 1.12
Pg 113.0573 C6H9O2 1.8 3.02E-07 5.55E-09 yes no 0.94 1.38
Pg 115.0355 C5H7O3 23 7.75E-04 2.29E-06 yes no 0.20 0.23
Pg 115.0730 C6H11O2 0.2 2.48E-07 4.87E-09 yes no 0.75 0.85
Pg 116.0498 C8H6N 9.3 1.00E-06 1.23E-08 yes no 0.62 0.44
Pg 116.0680 C5H10NO2 1.8 3.62E-09 3.11E-10 yes no 0.84 1.08
Pg 121.0274 C7H5O2 8.3 1.42E-05 1.07E-07 yes no 1.19 1.26
Pg 125.0568 C7H9O2 3.2 4.59E-05 2.50E-07 yes no 0.33 0.40
Pg 125.0931 C8H13O 24 4.84E-07 7.30E-09 yes no 1.37 1.55
Pg 127.0732 C7H11O2 2 9.02E-09 4.82E-10 yes no 0.60 0.81
Pg 128.0754 C3H6N5O 2.2 1.30E-09 2.17E-10 yes no 0.67 0.84
Pg 128.1042 C7H14NO 0.2 1.11E-07 2.97E-09 yes yes 2.41 3.03
Pg 129.0511 C2H5N6O 1 7.85E-06 6.60E-08 yes no 0.68 0.68
Pg 129.0881 C7H13O2 0.8 2.28E-07 4.63E-09 yes no 0.77 0.83
Pg 130.0611 C9H8N 3.3 6.46E-06 5.51E-08 yes yes 2.50 2.67
Pg 130.0838 C6H12NO2 2.7 3.04E-04 1.11E-06 yes no 1.21 1.68
Pg 132.0995 C6H14NO2 3.1 1.61E-08 7.90E-10 yes no 1.34 1.73
Pg 134.0785 C5H12NO3 2.8 9.89E-04 2.71E-06 yes not present – –
Pg 136.0722 C8H10NO 21 2.11E-05 1.39E-07 yes no 0.93 1.32
Pg 137.0216 C7H5O3 7.9 1.13E-05 8.99E-08 yes yes 2.35 2.75
Pg 138.0143 C6H4NO3 31 6.63E-05 3.33E-07 yes yes 2.49 2.89
Pg 140.1120 C8H14NO 31 1.70E-06 1.96E-08 yes no 0.55 0.64
Pg 141.0990 C8H13O2 2.9 2.54E-04 9.63E-07 yes not present – –
Pg 143.1035 C8H15O2 1.8 1.18E-05 9.23E-08 yes no 0.87 0.80
Pg 144.1349 C8H18NO 4.1 7.70E-05 3.73E-07 yes no 1.75 2.51
Pg 145.0988 C6H13N2O2 1.8 9.63E-04 2.68E-06 yes no 0.41 0.43
Continued
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Bacterial 
strain m/z Sum formula
Mass deviation from 
experimental mass 
(ppm)
in vitro comparisons
Present in patient’s 
saliva  
(IAI Pado-Test 4.5)
Enhanced 
in patient 
vs. controls
Enhancement ratio
p value q value
patient/
control 1
patient/
control 2
Pg 147.0421 C9H7O2 2.4 8.27E-04 2.42E-06 yes no 0.27 0.31
Pg 148.0756 C9H10NO 0.6 7.67E-04 2.28E-06 yes yes 4.07 4.39
Pg 149.0780 C6H13O4 2.2 5.36E-04 1.71E-06 yes no 1.27 2.02
Pg 153.0607 C8H9O3 2.1 1.06E-03 2.87E-06 yes not present – –
Pg 155.1042 C9H15O2 1.7 6.00E-06 5.35E-08 yes no 0.60 0.92
Pg 157.1191 C9H17O2 1.9 3.70E-09 3.11E-10 yes no 0.56 0.65
Pg 158.0824 C7H12NO3 13 2.31E-05 1.51E-07 yes not present – –
Pg 158.1515 C9H20NO 17 2.82E-04 1.06E-06 yes yes 7.06 8.68
Pg 159.1093 C7H15N2O2 2.5 2.63E-05 1.63E-07 yes yes 2.04 2.96
Pg 162.0949 C7H16NOS 1.2 3.69E-04 1.28E-06 yes not present – –
Pg 163.0716 C6H7N6 2.3 9.74E-05 4.41E-07 yes no 0.63 0.76
Pg 165.0992 C10H13O2 4.3 6.82E-03 1.20E-05 yes yes 2.06 2.76
Pg 171.0982 C5H11N6O 0.5 5.19E-05 2.73E-07 yes no 0.94 1.33
Pg 171.1351 C6H15N6 1 1.29E-10 3.80E-11 yes no 0.64 0.79
Pg 171.1461 C9H19N2O 2.3 7.37E-08 2.20E-09 yes no 1.91 2.42
Pg 172.1664 C10H22NO 2.3 2.57E-03 5.41E-06 yes no 1.65 1.82
Pg 175.1297 C5H15N6O 1.1 1.39E-04 5.97E-07 yes no 1.98 2.21
Pg 179.0607 C9H11N2S 3.6 6.86E-05 3.42E-07 yes no 1.06 1.69
Pg 179.1042 C7H11N6 1 1.26E-06 1.51E-08 yes no 0.48 0.59
Pg 182.1148 C10H16NO2 15 1.97E-05 1.32E-07 yes not present – –
Pg 185.1506 C11H21O2 3.8 4.34E-07 7.09E-09 yes no 0.47 0.53
Pg 189.1455 C10H21O3 3.8 1.37E-03 3.34E-06 yes yes 2.34 2.52
Pg 191.1394 C13H19O 3.4 1.46E-07 3.43E-09 yes no 0.67 0.88
Pg 192.1645 C9H22NO3 26 6.97E-05 3.42E-07 yes not present – –
Pg 193.1416 C9H21O4 3.8 3.64E-05 2.12E-07 yes no 3.10 0.91
Pg 195.1349 C12H19O2 4.9 2.13E-04 8.45E-07 yes no 0.60 0.67
Pg 199.1299 C7H15N6O 8.5 3.30E-04 1.18E-06 yes no 0.62 0.88
Pg 199.1676 C12H23O2 1.3 8.04E-07 1.06E-08 yes no 1.15 1.28
Pg 201.1095 C10H17O4 4.2 4.80E-07 7.30E-09 yes no 1.59 2.37
Pg 204.1399 C13H18NO 7.9 5.05E-09 3.30E-10 yes yes 3.35 4.18
Pg 205.1409 C10H21O4 3.6 2.29E-04 8.82E-07 yes no 1.30 2.33
Pg 206.1358 C9H20NO4 14 2.28E-06 2.48E-08 yes not present – –
Pg 214.0884 C10H16NO2S 3.4 1.90E-04 7.69E-07 yes no 0.18 0.22
Pg 235.1863 C15H23O2 3.6 2.60E-05 1.62E-07 yes not present – –
Pg 236.1563 C10H22NO5 30 8.80E-05 4.08E-07 yes not present – –
Pg 251.1842 C12H27O5 2.8 1.55E-04 6.45E-07 yes yes 7.77 7.74
Td 119.0570 C7H7N2 28 1.84E-04 7.57E-07 yes not present – –
Td 120.0641 C4H10NO3 1.8 7.35E-04 2.22E-06 yes no 0.02 0.03
Td 120.0796 C3H10N3O2 11 5.00E-04 1.63E-06 yes no 0.67 0.41
Td 121.0819 C5H13O3 3.5 4.33E-04 1.44E-06 yes yes 2.47 2.36
Td 136.1085 C9H14N 2 7.73E-05 3.73E-07 yes no 0.53 1.09
Td 136.1299 – – 1.18E-03 3.06E-06 yes no 0.02 0.03
Td 150.1237 C5H16N3O2 25 2.55E-03 5.40E-06 yes no 0.57 0.60
Tf 44.0492 C2H6N 6.2 6.46E-05 3.30E-07 yes not present – –
Tf 50.0164 – – 9.77E-04 2.70E-06 yes not present – –
Tf 53.0378 C4H5 15 5.14E-04 1.65E-06 yes not present – –
Tf 55.0279 C2H3N2 21 4.49E-09 3.30E-10 yes not present – –
Continued
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number of bacteria in four dental pockets). It has to be stated that only in 2 of 4 pockets the bacteria 
were present, although all pockets had a periodontal screening index equal to 4, which is the highest 
possible score for the disease. As expected, none of the four oral bacteria strains were found in the dental 
pockets of the controls. Out of the 120 bacteria-specific compounds identified in vitro, 94 were found to 
be present in saliva. This is consistent with previous studies showing that the transfer of potential mark-
ers from in vitro to in vivo is not always possible, due to different conditions such as different media23. 
Remarkably, 18 of these compounds were systematically present with enhanced ion intensities in the 
patient in comparison to the healthy controls. 13 compounds were related to P. gingivalis, 4 to T. forsythia 
and 1 to T. denticola. These compounds were systematically enhanced in the patient’s saliva as compared 
to the two controls (average patient/control ratio 4.7 and 4.6 for both controls). Supplementary Table S3 
lists ion intensities and patient/controls ratios for each of the 120 molecules of interest. While the num-
ber of participants in this study is limited, the fact that 18 molecules are systematically detected both in 
in vitro cultures and enhanced in the saliva of a patient suffering periodontitis, supports the hypothesis 
that pathogen-related volatiles could be used as indicators of periodontitis development.
Conclusions
We have shown that with simple modifications of the atmospheric pressure interface of commercial mass 
spectrometers, a rapid screening of volatiles found in the headspace of bacterial cultures and saliva is 
feasible. SESI-MS produced rich mass spectrometric fingerprints of volatiles with masses up to > 200 Da. 
In addition, the high accuracy and high mass resolution of the MS systems used in this study enabled us 
to provide molecular formulae of the bacteria-related chemicals with high confidence.
Bacterial 
strain m/z Sum formula
Mass deviation from 
experimental mass 
(ppm)
in vitro comparisons
Present in patient’s 
saliva  
(IAI Pado-Test 4.5)
Enhanced 
in patient 
vs. controls
Enhancement ratio
p value q value
patient/
control 1
patient/
control 2
Tf 55.0530 C4H7 24 5.54E-08 2.04E-09 yes no 0.65 0.52
Tf 60.0801 C3H10N 1.3 3.22E-05 1.92E-07 yes no 0.55 0.92
Tf 70.0716 – – 4.08E-07 6.86E-09 yes not present – –
Tf 73.0441 C2H5N2O 43 8.28E-07 1.06E-08 yes no 0.22 0.22
Tf 73.0623 C4H9O 33 1.30E-07 3.19E-09 yes yes 3.37 2.97
Tf 76.0809 – – 1.57E-07 3.56E-09 yes not present – –
Tf 77.0362 C6H5 31 7.41E-07 1.04E-08 yes no 0.37 0.31
Tf 79.0515 C6H7 34 2.72E-07 5.17E-09 yes no 0.34 0.27
Tf 87.0785 C5H11O 13 6.23E-08 2.16E-09 yes no 1.51 1.09
Tf 89.0577 C4H9O2 2.3 4.73E-04 1.54E-06 yes no 1.31 1.19
Tf 92.0486 C6H6N 9.5 6.21E-07 8.91E-09 yes no 0.20 0.07
Tf 96.0859 C6H10N 53 9.65E-05 4.40E-07 yes no 0.49 0.47
Tf 100.0180 C2H3N2O2 38 3.23E-04 1.16E-06 yes yes 5.12 2.79
Tf 103.0630 C2H7N4O 13 1.75E-05 1.23E-07 yes not present – –
Tf 103.0729 C5H11O2 1.5 1.77E-06 2.01E-08 yes no 0.64 0.60
Tf 107.0463 C2H7N2O3 14 3.30E-07 5.88E-09 yes no 0.29 0.29
Tf 109.0516 C3H9O4 19 4.33E-05 2.42E-07 yes not present – –
Tf 109.0981 C8H13 2.5 5.06E-06 4.73E-08 yes no 1.26 0.81
Tf 115.1081 C7H15O 3 2.78E-08 1.17E-09 yes no 0.98 0.66
Tf 116.1120 C6H14NO 43 4.00E-04 1.36E-06 yes not present – –
Tf 123.1131 C9H15 1.8 5.57E-06 5.04E-08 yes no 0.29 0.43
Tf 127.1082 C8H15O 1.1 1.70E-05 1.20E-07 yes yes 12.17 8.27
Tf 142.0290 C9H4NO 1.8 4.13E-12 2.43E-12 yes yes 17.36 13.13
Tf 142.0474 C6H8NO3 17 2.52E-05 1.59E-07 yes not present – –
Tf 183.1711 C12H23O 4.6 1.65E-05 1.19E-07 yes no 0.31 0.32
Tf 189.1261 C13H17O 6.8 7.80E-04 2.29E-06 yes no 0.78 0.59
Table 1. List of 120 discriminative compounds for in vitro bacteria cultures of A. 
actinomycetemcomitans (n = 13), P. gingivalis (n = 70), T. denticola (n = 7) and T. forsythia (n = 30). 
Compounds in bold were found at least a factor of two more intense in the saliva of the patient vs. two 
controls.
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During the initial headspace analysis of pure bacterial cultures, we were able to differentiate four oral 
bacteria strains: A. actinomycetemcomitans, P. gingivalis, T. denticola, and T. forsythia. The 120 most dis-
criminative compounds found in vitro were then used for targeted analysis of the saliva samples from a 
severe periodontitis patient and two healthy controls. As a result, we found a set of 18 compounds highly 
increased in the saliva of the patient as compared to the controls. We conclude that this method has 
potential for clinical diagnosis of bacterial infections in the oral cavity such as periodontitis. Follow-up 
measurements with a larger cohort of patients and healthy controls should be accomplished to validate 
these preliminary results and to correlate the absolute number of oral bacteria with the volatile com-
pounds abundance.
Methods
Bacteria cultures. Aggregatibacter actinomycetemcomitans and P. gingivalis were cultivated on 
Colombia Blood Agar (CBA) plates and afterwards used to inoculate 10 mL of a Brain Heart Infusion 
(BHI) liquid medium, under aerobic (A. actinomycetemcomitans) or anaerobic (P. gingivalis) condi-
tions, at 37 °C. In the next step, 5% of the liquid culture was sub-cultivated under the same conditions 
for 24 hours. Treponema denticola was cultivated under anaerobic conditions in 10 mL of spirochetes 
medium OMIZ-W6824 for 5 days, and thereafter 10% of this volume were sub-cultured into the same 
medium and cultivated anaerobically at 37 °C for 8 days. Tannerella forsythia was cultivated under anaer-
obic conditions for 3 days. Thereafter, 10% volume was transferred in modified25 spirochetes medium 
OMIZ-W6824, and thereafter sub-cultured anaerobically at 37 °C for 3 days. All bacteria suspensions were 
adjusted to an optical density (OD) 550 nm = 0.5 and centrifuged at 4’200 rpm (3’600 g) for 10 minutes, at 
4 °C. The supernatants were finally sterilized by filtration (pore diameter 0.2 μ m), transferred into 20 mL 
glass vials with septa (Infochroma, Zug, Switzerland) and stored at − 20 °C until further use. From each 
bacterial strain, five biological replicates were produced. It is important to note the bacteria were cultured 
in vitro in different specific media: BHI for A. actinomycetemcomitans and P. gingivalis; OMIZ-W68 for 
T. denticola and modified OMIZ-W68 for T. forsythia. To counteract artefact volatiles resulting from 
different media, the media were pooled prior headspace analysis.
Human subjects and standard oral bacteria tests. All three study participants were non-smoking 
male volunteers. One patient with severe periodontitis and two healthy controls were selected for the 
explorative targeted analysis of the human saliva samples. The participants were examined for their 
periodontitis status by a dentist. During a periodontal basic examination (PGU) the periodontal screen-
ing index (PSI) in six dental areas was measured. The criteria to be patient was to have a PSI of four 
(periodontal pocket depth deeper than 5.5 mm) in at least two of the dental sextants. A healthy control 
should have a maximum PSI of one (periodontal pocket depth not deeper than 3.5 mm) in all sextants. In 
addition, the absolute number of bacteria for all four strains (A. actinomycetemcomitans, P. gingivalis, T. 
denticola, T. forsythia) was determined in four periodontal pockets (teeth no. 16, 25, 36 and 46) with the 
commercially available IAI Pado-Test 4.5 (IAI AG, Zuchwil, Switzerland). The ethical committee of the 
Kanton Zürich (KEK, Stampfenbachstrasse 121, 8090 Zürich) approved the experiments (KEK-ZH-Nr. 
2013–0353) and all volunteers gave written informed consent to participate. All experiments were carried 
out in accordance with the approved protocol.
Figure 3. Projection of the mass spectra from the biological replicates of the four different bacteria 
strains A. actinomycetemcomitans (circles), P. gingivalis (squares), T. denticola (triangles) and T. 
forsythia (rhomboids) onto a two-dimensional PCA subspace. The replicates are clustering and the strains 
distinguishable from each other.
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Sample preparation
Bacteria cultures. In the cultivation experiments three different media (BHI, OMIZ-W86, modified 
OMIZ-W86) were used. To avoid the assignment of media compounds as potential bacteria strain mark-
ers, all samples were spiked with the two remaining media. For example, 100 μ L of the Aa or Pg samples 
were spiked with 100 μ L OMIZ-W86 and 100 μ L modified OMIZ-W86 medium, and likewise for the 
other two media. And 100 μ L of each Tf sample was spiked with 100 μ L BHI and 100 μ L OMIZ-W86 
medium. After vortexing, the sample vials were flushed with pressurized air (medicinal air, Pangas, 
Dagmersellen, Switzerland) with a flow rate of 2 L min−1.
Human saliva samples. From all test subjects 1–2 mL saliva were sampled into 20 mL glass vials 
(Infochroma, Zug, Switzerland) after they had not drunk, eaten, smoked or cleaned their teeth for one 
hour. The samples were stored at − 18 °C between sampling and analysis. Before the measurements, the 
sample vials were brought to room temperature and flushed with pressurized air (medicinal air, Pangas, 
Dagmersellen, Switzerland) with a flow rate of 2 L min−1.
Secondary electrospray ionization – mass spectrometry (SESI-MS). For this type of metab-
olomic analysis, a quadrupole time-of-flight instrument was chosen because of its high resolution 
and sensitivity. We interfaced a home-built SESI source with a TripleTOF 5600+ mass spectrometer 
(10’000 resolution at m/z 40 to 32’000 resolution at m/z 450/Applied Biosystems Sciex, Toronto, ON, 
Canada/Fig.  4). The standard ESI source was removed, the SESI source was installed on the “curtain 
plate” and the original curtain gas was replaced by an auxiliary gas supply (2.4 L min−1 of high purity 
nitrogen, heated to 60 °C). The SESI source consisted of a cylindrical stainless steel reaction chamber 
with two observation windows (glass), two inlets (nano electrospray and sample delivery) and one outlet 
(backpressure vent). Coaxially with the inlet of the mass spectrometer, an uncoated fused silica capil-
lary (id 20 μ m, TaperTip Emitters, New Objectives, Woburn, MA, USA) was fixed in the chamber wall 
to establish a nano electrospray. The spray was pneumatically (approx. 500 mbar overpressure of air) 
supplied with nanopure water (resistivity 18.2 MΩ cm, Barnstead Nanopure, Thermo Fisher Scientific, 
Waltham, MA, USA) and 0.1% formic acid (98%, for MS, Fluka, Sigma-Aldrich, Buchs, Switzerland) 
as solvent. To establish the nanoES, high voltage (3.6 kV) was taken from the mass spectrometer and 
applied to the solvent reservoir via a platinum wire. The nanoES was optically and electrically checked 
by a microscope (Specwell) and a multimeter (Uni-Trend, China). The spray current was optimized to 
Figure 4. (a) Gas tight syringe with a headspace sample from the bacteria cultures (b) SESI reaction 
chamber with nano electrospray mounted coaxially with the mass spectrometer inlet. The sample was 
injected into the chamber, where secondary ionization takes place. (c) Quadrupole time-of-flight hybrid 
mass spectrometer for analyzing the ionized headspace samples in real-time. (d) Schematic diagram of the 
sample introduction system into the SESI-MS system. Photos are reproduced with permission, courtesy of 
AB Sciex Pte. Ltd.
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60–80 nA. The backpressure vent (Legris, Parker, Mesa, AZ, USA) was optimized for maximum signal 
intensity while introducing air with an overpressure of 10 mbar into the reaction chamber.
For analysis, 10 mL headspace were extracted from the sample vials with a gas tight syringe (10 mL, 
Hamilton, Reno, NV, USA) and injected into the reaction chamber were secondary ionization by the 
nano-electrospray took place. For each bacterial strain and human subject, a clean syringe was used. 
The mass spectrometer was acquiring mass spectra (m/z 40–450) in positive ionization mode with an 
accumulation time of 1 s.
Compound identification. For further identification of the found biomarker with sum formula 
determination, the SESI source described for the TripleTOF 5600+ was adapted to a LTQ Orbitrap 
high-resolution mass analyzer (Thermo Fisher Scientific, Waltham, MA, USA) that has a resolution 
of 300’000 at m/z 60 to 100’000 at m/z 400. 100 μ L of all 4 in vivo cultured bacteria samples spiked 
with the different media were mixed together and flushed with pressurized air (medicinal air, Pangas, 
Dagmersellen, Switzerland) with a flow rate of 2 L min−1. Afterwards 10 mL headspace were extracted 
and injected into the SESI – Orbitrap mass analyzer. The mass spectrometer was acquiring mass spectra 
(m/z 50–450) in positive ionization mode with an accumulation time of 1 s. Based on the exact mass 
sum formulae were provided based on the seven golden rules for sum formula determination by mass 
spectrometry26.
Data Analysis
Data pre-processing. The data was acquired and mass calibrated with the Analyst TF 1.7 and 
PeakView 2.1 software (Applied Biosystems Sciex, Toronto, ON, Canada). The mass spectrometric spec-
tra of all bacteria culture supernatant and individual medium sample injections were exported as txt 
files. All subsequent data analysis was done with Matlab 2014a (MathWorks, Natick, MA, USA). (i) 
All the spectra were resampled using a linear interpolation function (2’000’000 data points across the 
40–450 m/z range); (ii) to remove systematic variation between spectra, we applied median normaliza-
tion; (iii) The spectra were centroided. An intensity threshold of 50 counts was set resulting in 1,966 
features. Subsequently, signals that rise with time upon sample injection were identified. As a result, 547 
of the 1’966 features were retained for further data analysis.
Statistical analysis. The next step was to filter out the most informative features to discriminate 
one bacterial strain from the others. We pursued a univariate approach for this task. Thus, a compar-
ison of differences in each of the detected compounds in the headspace of the bacterial samples was 
assessed by ANOVA or Kruskal-Wallis tests for normally and non-normally distributed data, respec-
tively. Normality of the data was evaluated using a Lilliefors test. It followed a pairwise comparison by 
using a Tukey-Kramer procedure. Statistical significance was set at p-value ≤ 0.05. The false discovery 
rate for multiple hypothesis testing was estimated using the procedure introduced by Storey27.
This procedure delivered 464 statistically significant features. We further selected those which had 
significantly low intensity for three bacterial strains and an enhanced intensity for one bacterial strain 
which means that the p-values (from multiple comparison) between the specific strain and the other 
strains had to be lower than 0.05. In addition, the feature intensity in the medium sample had to be 
lower than in the bacteria samples. This procedure reduced the list of discriminative features to 149. A 
closer inspection of these features revealed the presence of redundant 13C isotopes, finally reducing the 
list to 120 discriminatory signals. Further dimensionality reduction was accomplished by subjecting the 
normalized 20 x 120 (samples x features) matrix to a principal component analysis (PCA) for better vis-
ualization of the data. For the targeted saliva analysis, the ion intensities of the 120 in vitro signals were 
compared between the patient and the two healthy controls. An arbitrary 2-fold intensity enhancement 
cut-off value was used to determine whether the compounds were enhanced in the saliva of the patient 
vs. the healthy controls.
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